162 related articles for article (PubMed ID: 23408949)
21. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens.
Ramsland PA; Farrugia W; Bradford TM; Mark Hogarth P; Scott AM
J Mol Biol; 2004 Jul; 340(4):809-18. PubMed ID: 15223322
[TBL] [Abstract][Full Text] [Related]
22. The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.
Velders MP; van Rhijn CM; Oskam E; Fleuren GJ; Warnaar SO; Litvinov SV
Br J Cancer; 1998 Aug; 78(4):478-83. PubMed ID: 9716030
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.
Yang J; Baskar S; Kwong KY; Kennedy MG; Wiestner A; Rader C
PLoS One; 2011; 6(6):e21018. PubMed ID: 21698301
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody.
Garkavij M; Tennvall J; Strand SE; Sjögren HO; JianQing C; Nilsson R; Isaksson M
J Nucl Med; 1997 Jun; 38(6):895-901. PubMed ID: 9189138
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of BR96 sFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinoma.
Henry CJ; Buss MS; Hellström I; Hellström KE; Brewer WG; Bryan JN; Siegall CB
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):751-5. PubMed ID: 15701865
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of a specific IgG monoclonal antibody toward the Lewis x antigen using splenocytes of Schistosoma mansoni-infected mice.
Mandalasi M; Dorabawila N; Smith DF; Heimburg-Molinaro J; Cummings RD; Nyame AK
Glycobiology; 2013 Jul; 23(7):877-92. PubMed ID: 23542315
[TBL] [Abstract][Full Text] [Related]
27. Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.
Rosales C; Jeglum KA; Obrocka M; Steplewski Z
Cell Immunol; 1988 Sep; 115(2):420-8. PubMed ID: 3409330
[TBL] [Abstract][Full Text] [Related]
28. Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer.
Stahel RA; Lacroix H; Sculier JP; Morant R; Richner J; Janzek E; Loibner H; Blythman H
Ann Oncol; 1992 Apr; 3(4):319-20. PubMed ID: 1327079
[No Abstract] [Full Text] [Related]
29. Differential lytic and agglutinating activity of the anti-Lewis(x) monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies.
Capurro M; Ballaré C; Bover L; Portela P; Mordoh J
Cancer Immunol Immunother; 1999; 48(2-3):100-8. PubMed ID: 10414463
[TBL] [Abstract][Full Text] [Related]
30. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
31. Phage display generation of a novel human anti-CD1A monoclonal antibody with potent cytolytic activity.
Bechan GI; Lee DW; Zajonc DM; Heckel D; Xian R; Throsby M; van Meijer M; Germeraad WT; Kruisbeek AM; Egeler RM; Arceci RJ
Br J Haematol; 2012 Nov; 159(3):299-310. PubMed ID: 22934889
[TBL] [Abstract][Full Text] [Related]
32. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
33. Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassay.
Mantovani L; Azzini V; Canevari S; Danzi R; Fontanelli R; Leoni F; Ménard S; Miotti S; Pasquali M; Zambetti M
Int J Biol Markers; 1989; 4(4):197-202. PubMed ID: 2483408
[TBL] [Abstract][Full Text] [Related]
34. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
Robak T; Robak E
BioDrugs; 2011 Feb; 25(1):13-25. PubMed ID: 21090841
[TBL] [Abstract][Full Text] [Related]
35. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide.
Simoons-Smit IM; Appelmelk BJ; Verboom T; Negrini R; Penner JL; Aspinall GO; Moran AP; Fei SF; Shi BS; Rudnica W; Savio A; de Graaff J
J Clin Microbiol; 1996 Sep; 34(9):2196-200. PubMed ID: 8862584
[TBL] [Abstract][Full Text] [Related]
36. A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab.
Rosok MJ; Yelton DE; Harris LJ; Bajorath J; Hellström KE; Hellström I; Cruz GA; Kristensson K; Lin H; Huse WD; Glaser SM
J Biol Chem; 1996 Sep; 271(37):22611-8. PubMed ID: 8798431
[TBL] [Abstract][Full Text] [Related]
37. Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity.
Sawada R; Sun SM; Wu X; Hong F; Ragupathi G; Livingston PO; Scholz WW
Clin Cancer Res; 2011 Mar; 17(5):1024-32. PubMed ID: 21343375
[TBL] [Abstract][Full Text] [Related]
38. Determination of immunoreactivity of doxorubicin antibody immunoconjugates by a Le(y) competitive RIA.
Zhao H; Willner D; Cleaveland JS; Braslawsky GR; Brown JP
Bioconjug Chem; 1992; 3(6):549-53. PubMed ID: 1361153
[TBL] [Abstract][Full Text] [Related]
39. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
Livingston PO; Hood C; Krug LM; Warren N; Kris MG; Brezicka T; Ragupathi G
Cancer Immunol Immunother; 2005 Oct; 54(10):1018-25. PubMed ID: 15926079
[TBL] [Abstract][Full Text] [Related]
40. Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens.
Hellström I; Garrigues HJ; Garrigues U; Hellström KE
Cancer Res; 1990 Apr; 50(7):2183-90. PubMed ID: 1690595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
